19 June 2026
Wolfram Resources Plc
Interim Results for the Six Months Ended 31 March 2026
I am pleased to present the interim results for Wolfram Resources Plc (the "Company") for the period ended 31 March 2026. The Company was admitted to the Standard Listing of the Main Market of the London Stock exchange on 5 June 2023 (XLON: WFR).
Chairman's Statement
During the period the Company made a loss of £51,773, compared with a loss of £226,161 for the same period last year. The Company is operating on a skeleton basis to ensure the loss is as low as possible. The Board are not currently taking a salary whilst they have been diligently procuring an established business or businesses in the strategic metals and rare earth assets. The Board has been working attentively to reduce the administrative costs of the Company, reducing salaries and outsourced administrative assistance. As at 31 March 2026, the Company's cash position was £10,367 (2025: £84,983).
These interim results have not been audited by the Company's auditor.
Post period events
Since the end of the reported period, the Company has continued to actively pursue alternative acquisition opportunities involved in strategic metals and rare earth assets.
Directors of the company
The directors who have served during the period and up to the date of approval were as follows:
Graeme Muir
(Chairman)
Daniel Monks
(Executive Director)
Results and dividends
The interim statement of comprehensive income is set out on page 3 and shows the loss for six month period to 31 March 2026. The directors consider the loss for the period to be in line with expectations. The directors do not recommend a payment of a dividend.
This report was approved by the Board and signed on its behalf:
Graeme Muir
Chairman
The Directors of the Company accept responsibility for the content of this announcement.
Enquiries:
Company
Woldram Resources Plc
Graeme Muir
gm@becketinvest.co.uk
www.wolframresources.com
Corporate Advisor
AlbR Capital Limited
Telephone: 020 7469 0930
Statement of Comprehensive Income for the 6 months ended 31 March 2026
6 months to
31 March 2026
Unaudited
Year ended
30 September 2025
Audited
6 months to
31 March 2025
Unaudited
£
£
£
Administrative expenses
(51,773)
(373,217)
(226,161)
Warrant expense
-
-
-
Operating Profit / (Loss)
(51,773)
(373,217)
(226,161)
Taxation
-
-
-
Loss for the period from continuing operations
(51,773)
(373,217)
(226,161)
Other comprehensive income
-
-
-
Total comprehensive income for the period
(51,773)
(373,217)
(226,161)
Earnings per share
Basic earnings per share
(0.06p)
(0.46p)
(0.277p)
Diluted earnings per share
(0.01p)
(0.15p)
(0.039p)
Statement of Financial Position for the 6 months ended 31 March 2026
6 months to
31 March 2026
Unaudited
Year ended
30 September 2025
Audited
6 months to
31 March 2025
Unaudited
£
£
£
Assets
Current assets
Trade and other receivables
8,801
20,745
13,143
Cash and cash equivalents
10,367
4,099
84,983
19,168
24,844
98,126
Total assets
19,168
24,844
98,126
Current liabilities
Trade and other payables
35,250
89,153
15,379
Non-current liabilities
Parent company loan
100,000
-
-
Net assets
(116,082)
(64,309)
82,747
Capital and reserves
Share capital
820,001
820,001
820,001
Warrant reserves
2,093,571
2,093,571
2,093,571
Retained earnings
(3,029,654)
(2,977,881)
(2,830,825)
Total equity
(116,082)
(64,309)
82,747
Statement of Changes in Equity for the 6 months ended 31 March 2026
Share
Warrant
Retained
Total
capital
reserves
Earnings
£
£
£
£
As at 1 October 2024
820,001
2,093,571
(2,604,664)
308,908
Profit / (Loss) for the period
-
-
(226,161)
(226,161)
Total comprehensive income
-
-
(226,161)
(226,161)
Balance at 31 March 2025
820,001
2,093,571
(2,830,825)
82,747
Loss for the year
-
-
(373,217)
(373,217)
Total comprehensive income
-
-
(373,217)
(373,217)
Balance at 30 September 2025
820,001
2,093,571
(2,977,881)
(64,309)
Loss for the period
-
-
(51,773)
(51,773)
Total comprehensive income
-
-
(51,773)
(51,773)
Balance at 31 March 2026
820,001
2,093,571
(3,029,654)
(116,082)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END IR EASKNFEDKEFA